Business Description
Aristo Bio-Tech and Lifescience Ltd
ISIN : INE082101010
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 0.62 | |||||
Debt-to-EBITDA | 2.33 | |||||
Interest Coverage | 3.65 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.13 | |||||
Beneish M-Score | -2.19 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.7 | |||||
3-Year EBITDA Growth Rate | 26.2 | |||||
3-Year EPS without NRI Growth Rate | 40.1 | |||||
3-Year FCF Growth Rate | 52.5 | |||||
3-Year Book Growth Rate | 35.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 95.95 | |||||
9-Day RSI | 86.7 | |||||
14-Day RSI | 79.06 | |||||
6-1 Month Momentum % | 41.67 | |||||
12-1 Month Momentum % | 28.52 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.26 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 53.19 | |||||
Days Sales Outstanding | 88.02 | |||||
Days Payable | 97.54 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.25 | |||||
Dividend Payout Ratio | 0.04 | |||||
Forward Dividend Yield % | 0.25 | |||||
5-Year Yield-on-Cost % | 0.25 | |||||
Shareholder Yield % | 3.66 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 6.18 | |||||
Operating Margin % | 2.95 | |||||
Net Margin % | 1.59 | |||||
FCF Margin % | 0.43 | |||||
ROE % | 12.13 | |||||
ROA % | 3.29 | |||||
ROIC % | 9.35 | |||||
3-Year ROIIC % | 16.59 | |||||
ROC (Joel Greenblatt) % | 14.16 | |||||
ROCE % | 17.55 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 25.17 | |||||
PE Ratio without NRI | 25.17 | |||||
Price-to-Owner-Earnings | 27 | |||||
PS Ratio | 0.4 | |||||
PB Ratio | 2.92 | |||||
Price-to-Tangible-Book | 3.24 | |||||
Price-to-Free-Cash-Flow | 93.72 | |||||
Price-to-Operating-Cash-Flow | 12.89 | |||||
EV-to-EBIT | 17.48 | |||||
EV-to-EBITDA | 14.42 | |||||
EV-to-Revenue | 0.52 | |||||
EV-to-FCF | 113.12 | |||||
Price-to-Graham-Number | 2.01 | |||||
Price-to-Net-Current-Asset-Value | 9.6 | |||||
Earnings Yield (Greenblatt) % | 5.73 | |||||
FCF Yield % | 0.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aristo Bio-Tech and Lifescience Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 2,451.479 | ||
EPS (TTM) (₹) | 5.72 | ||
Beta | 0 | ||
Volatility % | 57.92 | ||
14-Day RSI | 79.06 | ||
14-Day ATR (₹) | 9.402663 | ||
20-Day SMA (₹) | 132.125 | ||
12-1 Month Momentum % | 28.52 | ||
52-Week Range (₹) | 53.1 - 164 | ||
Shares Outstanding (Mil) | 6.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aristo Bio-Tech and Lifescience Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aristo Bio-Tech and Lifescience Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Aristo Bio-Tech and Lifescience Ltd Frequently Asked Questions
What is Aristo Bio-Tech and Lifescience Ltd(NSE:ARISTO)'s stock price today?
When is next earnings date of Aristo Bio-Tech and Lifescience Ltd(NSE:ARISTO)?
Does Aristo Bio-Tech and Lifescience Ltd(NSE:ARISTO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |